Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to explore the levels of internalized stigma in a sample of young patients with bipolar disorder or schizophrenia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The stigma is considered by patients, government organizations and health professionals a key point in mental illness (Griffiths et al, 2006). The related literature has focused on individuals with schizophrenia although there are indications that stigma act negatively in patients with bipolar disorder; this, in turn, is described in a few studies, always with heterogeneous samples, chronic and symptomatic patients (Perlick et al, 2001). It is also known that there is a significant association between affective symptoms and the presence of stigma, (Vázquez et al, 2010).

There are reports of higher levels of public stigma towards people with schizophrenia, compared to patients with bipolar disorder or unipolar depression, however there are no studies available on internalized stigma in such samples, especially in remitted patients . Since schizophrenia coexists with significant impairment of insight, such individuals may exhibit more difficulty internalizing the external bias and stereotypes. On the other hand, patients with bipolar disorder - despite being less discriminated by the public in relation to schizophrenia - probably have a high potential for self-stigma and its fearsome consequences, justified by higher levels of insight.

The investigators would like to examine whether the lower impairment of insight in young bipolar patients(in relation to young people with schizophrenia) could be accompanied by an increase in internalized stigma in this sample. It´s an observational, cross-sectional study with no intervention.

Hypothesis: the internalized stigma in young adults with bipolar disorder is identical to that of young patients with schizophrenia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stigma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

INTERNALIZED STIGMA INSIGHT SOCIAL ADEQUACY BIPOLAR DISORDER SCHIZOPHRENIA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bipolar Disorder Patients

Bipolar Disorder Patients, with age between 18 to 40 years old, at euthymic phase.

No interventions assigned to this group

Schizophrenia Patients

Schizophrenia Patients, with age between 18 to 40 years old, with minimum or none positive symptoms.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of bipolar disorder and schizophrenia according to DSM-IV-TR, presenting in euthymia (bipolar disorder) or without positive symptoms (schizophrenia), based on clinical assessment and confirmed by structured clinical interview SCID-P
* Age between 18 and 40 years
* Literate and able to understand the tasks required.
* Residents of Greater Sao Paulo.
* Patients and / or legal representatives must understand the nature of the study and sign an informed consent.

Exclusion Criteria

* Patients with Schizoaffective Disorder or Mental Retardation.
* Unstable serious diseases including kidney disease, gastroenterology, respiratory, cardiovascular, endocrine, neurological, immunological or haematological.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ricardo Alberto Moreno, M.D., Ph.D.

Ricardo Alberto Moreno

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ricardo Alberto Moreno, MD PhD

Role: STUDY_DIRECTOR

University of Sao Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PROGRUDA-Institute of Psychiatry- HCFMUSP

São Paulo, São Paulo, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Luis Felipe Oliveira Costa, M.D.

Role: CONTACT

Phone: +551198053654

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nayara Rodrigues, Secretary

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESTINT

Identifier Type: -

Identifier Source: org_study_id